Compound shows promise for minimizing erratic movements in Parkinson’s patients
South Africa’s new COVID cases double in 1 day amid omicron
1 December 2021WHO warns of ‘toxic mix’ as EU chief mulls mandatory COVID jabs
1 December 2021Compound shows promise for minimizing erratic movements in Parkinson’s patients
A new study from Texas Biomedical Research Institute (Texas Biomed) and collaborators has identified a promising drug candidate to minimize uncontrolled, erratic muscle movements, called dyskinesia, associated with Parkinson’s disease.
